202 related articles for article (PubMed ID: 10097041)
1. Luminal loop of the ryanodine receptor: a pore-forming segment?
Balshaw D; Gao L; Meissner G
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3345-7. PubMed ID: 10097041
[No Abstract] [Full Text] [Related]
2. A mutation in the human ryanodine receptor gene associated with central core disease.
Zhang Y; Chen HS; Khanna VK; De Leon S; Phillips MS; Schappert K; Britt BA; Browell AK; MacLennan DH
Nat Genet; 1993 Sep; 5(1):46-50. PubMed ID: 8220422
[TBL] [Abstract][Full Text] [Related]
3. Detection of a novel RYR1 mutation in four malignant hyperthermia pedigrees.
Keating KE; Quane KA; Manning BM; Lehane M; Hartung E; Censier K; Urwyler A; Klausnitzer M; Muller CR; Heffron JJ
Hum Mol Genet; 1994 Oct; 3(10):1855-8. PubMed ID: 7849712
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a role of the lumenal M3-M4 loop in skeletal muscle Ca(2+) release channel (ryanodine receptor) activity and conductance.
Gao L; Balshaw D; Xu L; Tripathy A; Xin C; Meissner G
Biophys J; 2000 Aug; 79(2):828-40. PubMed ID: 10920015
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia.
Quane KA; Healy JM; Keating KE; Manning BM; Couch FJ; Palmucci LM; Doriguzzi C; Fagerlund TH; Berg K; Ording H
Nat Genet; 1993 Sep; 5(1):51-5. PubMed ID: 8220423
[TBL] [Abstract][Full Text] [Related]
6. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
Monnier N; Romero NB; Lerale J; Nivoche Y; Qi D; MacLennan DH; Fardeau M; Lunardi J
Hum Mol Genet; 2000 Nov; 9(18):2599-608. PubMed ID: 11063719
[TBL] [Abstract][Full Text] [Related]
7. Haplotype analysis of the BYR1 gene in malignant hyperthermia and central core disease.
Quane KA; Keating KE; Healy JM; Heffron JJ; Lehane M; Krivosic-Horber R; Heytens L; McCarthy TV
Biochem Soc Trans; 1995 May; 23(2):372S. PubMed ID: 7672403
[No Abstract] [Full Text] [Related]
8. Ca2+ signaling in HEK-293 and skeletal muscle cells expressing recombinant ryanodine receptors harboring malignant hyperthermia and central core disease mutations.
Brini M; Manni S; Pierobon N; Du GG; Sharma P; MacLennan DH; Carafoli E
J Biol Chem; 2005 Apr; 280(15):15380-9. PubMed ID: 15689621
[TBL] [Abstract][Full Text] [Related]
9. Functional consequences of mutations of conserved, polar amino acids in transmembrane sequences of the Ca2+ release channel (ryanodine receptor) of rabbit skeletal muscle sarcoplasmic reticulum.
Du GG; MacLennan DH
J Biol Chem; 1998 Nov; 273(48):31867-72. PubMed ID: 9822655
[TBL] [Abstract][Full Text] [Related]
10. A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease.
Lynch PJ; Tong J; Lehane M; Mallet A; Giblin L; Heffron JJ; Vaughan P; Zafra G; MacLennan DH; McCarthy TV
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):4164-9. PubMed ID: 10097181
[TBL] [Abstract][Full Text] [Related]
11. Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease.
Tong J; Oyamada H; Demaurex N; Grinstein S; McCarthy TV; MacLennan DH
J Biol Chem; 1997 Oct; 272(42):26332-9. PubMed ID: 9334205
[TBL] [Abstract][Full Text] [Related]
12. Malignant hyperthermia-associated mutations in the S2-S3 cytoplasmic loop of type 1 ryanodine receptor calcium channel impair calcium-dependent inactivation.
Gomez AC; Holford TW; Yamaguchi N
Am J Physiol Cell Physiol; 2016 Nov; 311(5):C749-C757. PubMed ID: 27558158
[TBL] [Abstract][Full Text] [Related]
13. Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle.
Monnier N; Procaccio V; Stieglitz P; Lunardi J
Am J Hum Genet; 1997 Jun; 60(6):1316-25. PubMed ID: 9199552
[TBL] [Abstract][Full Text] [Related]
14. Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families.
Barone V; Massa O; Intravaia E; Bracco A; Di Martino A; Tegazzin V; Cozzolino S; Sorrentino V
J Med Genet; 1999 Feb; 36(2):115-8. PubMed ID: 10051009
[TBL] [Abstract][Full Text] [Related]
15. [Molecular pathology of malignant hyperthermia and central core disease].
Takagi A
Nihon Rinsho; 1997 Dec; 55(12):3307-14. PubMed ID: 9436456
[TBL] [Abstract][Full Text] [Related]
16. Clinical and functional effects of a deletion in a COOH-terminal lumenal loop of the skeletal muscle ryanodine receptor.
Zorzato F; Yamaguchi N; Xu L; Meissner G; Müller CR; Pouliquin P; Muntoni F; Sewry C; Girard T; Treves S
Hum Mol Genet; 2003 Feb; 12(4):379-88. PubMed ID: 12566385
[TBL] [Abstract][Full Text] [Related]
17. Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel Tyr to Ser mutation in a pedigree with associated central cores.
Quane KA; Keating KE; Healy JM; Manning BM; Krivosic-Horber R; Krivosic I; Monnier N; Lunardi J; McCarthy TV
Genomics; 1994 Sep; 23(1):236-9. PubMed ID: 7829078
[TBL] [Abstract][Full Text] [Related]
18. Malignant hyperthermia causing Gly2435Arg mutation of the ryanodine receptor facilitates ryanodine-induced calcium release in myotubes.
Brinkmeier H; Krämer J; Krämer R; Iaizzo PA; Baur C; Lehmann-Horn F; Rüdel R
Br J Anaesth; 1999 Dec; 83(6):855-61. PubMed ID: 10700782
[TBL] [Abstract][Full Text] [Related]
19. A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree.
Brown RL; Pollock AN; Couchman KG; Hodges M; Hutchinson DO; Waaka R; Lynch P; McCarthy TV; Stowell KM
Hum Mol Genet; 2000 Jun; 9(10):1515-24. PubMed ID: 10888602
[TBL] [Abstract][Full Text] [Related]
20. Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel (ryanodine receptor isoform 1).
Du GG; Oyamada H; Khanna VK; MacLennan DH
Biochem J; 2001 Nov; 360(Pt 1):97-105. PubMed ID: 11695996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
